Equity Analysis /
United States of America

US : argenx SE - ARGX | Framing Our Expectations for Ph 3: ITP's Complicated But Efgar's Utility Is Likely To ADVANCE

    Danielle Brill
    CGS-CIMB
    29 March 2022
    Published by